RE: Deary me!5 Dec 2023 09:32
Hi Pm01,
Thank you for your post and for clearly and articulately stating your position.
I’m certainly not saying this stock is without risk and it needs deals to be signed off. What I like is that currently they have a differentiated more diverse service offering, they are well funded into Q2 2025 and they seem to be being more proactive about getting this across the line finally.
My main bugbear was the “motives” of those trolling this stock without being invested or, as you have done, managing to give a decent argument why they’re trolling.
The coming weeks and months will be very telling and as a new investor I hope they succeed, not just for myself, but for long term investors and cancer research as a whole.